Pierre Marquet

Université de Limoges

Papers

1

Total Citations

102

H-Index

1

About

Pierre Marquet is a leading figure in clinical pharmacology and analytical toxicology, best known for pioneering therapeutic drug monitoring and mass spectrometry-based methods for anticancer agents. His seminal work on the simultaneous determination of anthracyclines and their metabolites in human serum—a method cited over 100 times—revolutionized the precise quantification of these potent chemotherapeutics, enabling safer, more personalized dosing regimens. Marquet’s research has profoundly advanced the understanding of drug metabolism and pharmacokinetics, particularly for drugs with narrow therapeutic windows. Beyond this landmark study, his contributions to the development of liquid chromatography–mass spectrometry (LC-MS) techniques have set new standards in clinical toxicology and forensic analysis. With a career spanning decades, Marquet has authored numerous highly cited papers and has been instrumental in translating complex analytical chemistry into practical clinical tools. His work continues to guide researchers and clinicians in optimizing drug therapy, reducing toxicity, and improving patient outcomes, solidifying his reputation as a transformative influence in pharmaceutical sciences.

Research Focus

Key Achievements

1
H-Index
1
Papers
102
Total Citations
102
Avg Citations/Paper
🏆 Most Cited Paper
Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography–electrospray mass spectrometry
102 citations · 2000
📈 Most Prolific Year: 2000 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Université de Limoges

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago